Steris Healthcare Expands South India Operations with New Distribution Hub in Kerala

The new facility is expected to streamline supply chain operations and ensure faster delivery to hospitals, pharmacies, and patients across Kerala.

Mumbai-based Steris Healthcare has announced its foray into Kerala by launching a new distribution center, marking a key milestone in its South India expansion strategy.

The pharmaceutical company, which recently crossed INR 100 Cr in annual sales, aims to strengthen its national footprint and improve access to affordable, high-quality medicines in the southern market.

The new facility is expected to streamline supply chain operations and ensure faster delivery to hospitals, pharmacies, and patients across Kerala.

Announcing the expansion, Jeevan Kasara, Director & CEO of Steris Healthcare, said, "'Our entry into Kerala marks a significant step in Steris Healthcare’s journey to becoming a pan-India healthcare solutions provider. South India represents a dynamic and rapidly growing market, and this new distribution center will allow us to serve our customers and partners with greater efficiency. We remain committed to delivering cutting-edge, affordable healthcare products that improve patient outcomes.”

The new distribution center is also expected to generate regional employment opportunities and foster stronger ties with local healthcare providers, distributors, and pharmacies.

Renuka Kasara, Director, Steris Healthcare, said, “Kerala’s robust healthcare infrastructure and progressive policies make it an ideal location for our expansion. By establishing a strong presence here, we aim to bridge gaps in healthcare accessibility while supporting local medical communities. This initiative aligns with our vision of making quality healthcare available to all.”

With a growing portfolio in critical therapeutic areas, Steris Healthcare continues to position itself as a trusted, innovation-driven pharmaceutical company committed to improving healthcare access across India.

Earlier, the pharmaceutical company announced an INR 50 Cr expansion strategy and plans to launch its Initial Public Offering (IPO) in the financial year 2026–27.

Stay tuned for more such updates on Digital Health News.

Stay tuned for more such updates on Digital Health News